Andere Sprachen Ziccum AB

Aktien

A2N6KZ

SE0011415595

ZICC

Verzögert Nasdaq Stockholm Andere Börsenplätze 16:49:26 17.05.2024			% 5 Tage	% 1. Jan.
5,94 ^SEK	+0,34 %		-7,48 %	-22,45 %

29.04.	Ziccum AB (publ) meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
14.03.	Ziccum AB (publ) Projekt für inhalierbare mRNA/LNP bestätigt hervorragende Eigenschaften von LaminarPace	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ziccum CEO Analyst video interview: Q1, 2024 highlights	06.05.
Ziccum AB strengthens patent portfolio with three solid data PCT applications according to expanded IP strategy	30.04.
Ziccum AB (publ) Interim report Q1 2024	29.04.
Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Ziccum contracts RFR Solutions for GMP manufacturing in next phase of technology scale-out	26.04.
Ziccum AB (publ) releases Annual Report 2023	15.04.
Ziccum CEO to present at first annual event for Biopharma/Biotech disruptors hosted by major US bank in New York City	10.04.
Ziccum strengthens and streamlines business and finance functions	03.04.
Ziccum inhalable mRNA/LNP project confirms excellent properties obtained by LaminarPace	14.03.
Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace	14.03.
Ziccum reports significant progress in 3D-modelling project with model completion	01.03.
Ziccum AB and project partner Zurich institute of Applied Sciences Updates LaminarPace Simulation Project Progress and Findings	01.03.
Ziccum announces last day of trading in BTU	26.02.
Ziccum announces outcome in rights issue	16.02.
Ziccums CEO Ann Gidner in Fireside Chat on mRNA development hosted by US Force Family Office	12.02.
Last day for trading in unit rights in Ziccum	09.02.
Ziccum's Board of Directors and Management Group use all their Unit Rights in the ongoing new share issue.	08.02.
Ziccum CEO video interview: mRNA in focus	05.02.
Join Ziccum CEO Ann Gidner for ‘Invest Live’, a live digital presentation and Q&A, Tues Feb 6th	03.02.
Ziccum has proven excellent mRNA activity in animal study with LaminarPace material	31.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ziccum AB

Aktien

A2N6KZ

SE0011415595

ZICC

Andere Sprachen

Filter